Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer
about
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and diseaseMolecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary fieldHIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers.Neoplasia: Where We Have Been and Where We Are GoingNeoplasia: the second decade.18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high.Cyclooxygenase-2 overexpression is common in serrated and non-serrated colorectal adenoma, but uncommon in hyperplastic polyp and sessile serrated polyp/adenomaThe SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growthPTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.Negative lymph node count is associated with survival of colorectal cancer patients, independent of tumoral molecular alterations and lymphocytic reactionEpigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors.Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.A cohort study of cyclin D1 expression and prognosis in 602 colon cancer cases.Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review.Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer.Cathepsin B expression and survival in colon cancer: implications for molecular detection of neoplasia.Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature reviewCDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival.STAT3 expression, molecular features, inflammation patterns, and prognosis in a database of 724 colorectal cancersAssociation of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer.Statin use and colorectal cancer risk according to molecular subtypes in two large prospective cohort studies.CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutationsCorrelation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer.Association Between Plasma Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal Cancer and Mortality.Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotype.IGFBP3 promoter methylation in colorectal cancer: relationship with microsatellite instability, CpG island methylator phenotype, and p53.Molecular classification and correlates in colorectal cancerRestriction of intestinal stem cell expansion and the regenerative response by YAP.Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer.PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations.Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer.Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasisDNA methylation in breast and colorectal cancers.Cohort study of fatty acid synthase expression and patient survival in colon cancer.Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression.Aurora-A expression is independently associated with chromosomal instability in colorectal cancer.Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancerCyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype.Interaction of molecular markers and physical activity on mortality in patients with colon cancer.Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers.
P2860
Q24289344-3741467B-F976-4D32-9DA4-1B768F4E155BQ24620628-C0C8887F-F323-4C44-9593-EEFAEA510FE6Q27851557-5FA7E304-89FD-4EF6-9405-E20817970C61Q28395095-6A26E7E8-A095-4D0C-8C13-B108A33B2B4DQ30484000-B4FFDB7D-C616-41FA-8FDB-EB60F17B6931Q33283458-B58C8CF7-5B4E-46ED-AFE4-DC69F765D85FQ33317095-4C00640A-48FC-4EC4-B266-04C9FA019C3AQ33328513-DDA21C2D-B63E-4904-9EB6-CA2DDCBC744BQ33723499-228EF992-C421-4EC3-9A9B-5E6A6602A6D5Q33883829-6FD07C82-CE98-4A17-959F-1C60A6AA9EFDQ33942280-68962EFC-EC69-4C18-B6DC-A42B69DE9AF1Q34051967-9B326506-1CBE-4FF5-9433-001A492B434CQ34066685-D74D33DA-1452-4F86-B9BD-2700C29DD743Q34217637-DB3D4916-E9CE-4562-8CFC-0AC36F1749E8Q34250109-599C8A9A-F7F0-4AD2-A5ED-7FA41C61CEB4Q34292820-E39E7C5D-1DC7-4BD6-9716-42675FA7CA40Q34551974-E9BF947A-AFEC-44EF-9114-355507CEA655Q34561921-0B4FD5F6-5584-4F7D-8092-D2E2A1613C30Q34796500-9E74D4E1-DFD0-4DA4-9AF5-DAA92DC411E1Q34921255-F2A56BA7-A740-479A-8C77-C44E00FC425BQ35332074-3C8A53C5-8739-4E32-AFFF-EF5798749DD3Q35807863-49732290-38F3-4E99-931D-7F6D5D2494F6Q35925139-A1FB3DD4-B51C-4041-ABCB-D79024622FB2Q35998469-A086C16F-2C0B-4A35-8BCF-4EDA470A7835Q36025343-9EF01040-6FA4-4310-AC68-EDCD65DB0D63Q36259638-C1EF9065-B87B-4639-9387-E87CEF72CB67Q36329300-5081B902-4E0F-4666-9CA7-9F2EE0CD7C72Q36508081-375730F4-E463-41D4-B2B2-C555DE71478FQ36563705-01DD1BD3-0684-43AE-BBB9-760BC92ABDB5Q36661711-5BD95405-762B-492A-88AF-C2607D37FE7CQ36733283-6BD5044B-AD61-47FE-9F0B-7580E9B187C9Q36750694-6DC40C3D-D2B6-457A-87B2-8D33386CF020Q36803766-DCC18D6C-1822-4478-94EE-84BE9438E7F4Q37071671-4B0D6AF9-7745-4302-9BF0-2A70EBCE55CBQ37081762-3165AE22-D0CE-4B87-98C4-D160DC311E9EQ37165838-3646F363-C775-41BB-BC37-6B473E636030Q37185554-C172AE9A-611B-4072-839B-3F30B4DFC610Q37286815-55CA3EED-4ABB-42D2-9C58-75B13CBDB0C6Q37350382-7DFD8ACD-7D8D-401C-97BD-666610355995Q37369820-F0342AA9-F27B-47A6-BDDC-791CF67900A8
P2860
Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Combined analysis of COX-2 and ...... phenotype in colorectal cancer
@ast
Combined analysis of COX-2 and ...... phenotype in colorectal cancer
@en
type
label
Combined analysis of COX-2 and ...... phenotype in colorectal cancer
@ast
Combined analysis of COX-2 and ...... phenotype in colorectal cancer
@en
prefLabel
Combined analysis of COX-2 and ...... phenotype in colorectal cancer
@ast
Combined analysis of COX-2 and ...... phenotype in colorectal cancer
@en
P2093
P2860
P356
P1433
P1476
Combined analysis of COX-2 and ...... phenotype in colorectal cancer
@en
P2093
Gregory J Kirkner
Mohan Brahmandam
Shuji Ogino
Takako Kawasaki
P2860
P304
P356
10.1593/NEO.06247
P577
2006-06-01T00:00:00Z